Compare · MMED vs RMD
MMED vs RMD
Side-by-side comparison of MiniMed Group Inc. (MMED) and ResMed Inc. (RMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MMED and RMD operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- RMD is the larger of the two at $33.55B, about 6.5x MMED ($5.13B).
- MMED has been more active in the news (9 items in the past 4 weeks vs 7 for RMD).
- RMD has more recent analyst coverage (25 ratings vs 17 for MMED).
- Company
- MiniMed Group Inc.
- ResMed Inc.
- Price
- -
- -
- Market cap
- $5.13B
- $33.55B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2026
- News (4w)
- 9
- 7
- Recent ratings
- 17
- 25
ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Latest MMED
- SEC Form SCHEDULE 13G filed by MiniMed Group Inc.
- MiniMed to Participate in Upcoming Investor Conferences
- MiniMed to Announce Its Fiscal Year 2027 Second Quarter Financial Results
- MiniMed Appoints Dr. David Segal as Chief Medical Officer
- EVP Ch. Prod. & Tech Officer Dianaty Ali covered exercise/tax liability with 449 shares, decreasing direct ownership by 0.14% to 325,817 units (SEC Form 4) (tax liability)
- SEC Form SCHEDULE 13G filed by MiniMed Group Inc.
- SEC Form 4 filed by MiniMed Group Inc.
- SEC Form 4 filed by MiniMed Group Inc.
- SEC Form 4 filed by MiniMed Group Inc.
- SEC Form 4 filed by MiniMed Group Inc.
Latest RMD
- Chairman and CEO Farrell Michael J. exercised 4,993 units of ResMed Common Stock at a strike of $146.34 and sold $1,175,089 worth of ResMed Common Stock (4,993 units at $235.35) as part of a pre-agreed trading plan (SEC Form 4)
- ResMed downgraded by Canaccord Genuity
- SEC Form 10-Q filed by ResMed Inc.
- SEC Form 8-K filed by ResMed Inc.
- Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027
- Global General Counsel Rider Michael J sold $102,000 worth of ResMed Common Stock (400 units at $255.00) as part of a pre-agreed trading plan (SEC Form 4)
- Resmed Launches AirTouch™ F40 Full Face Fabric CPAP Mask in the U.S.
- Chairman and CEO Farrell Michael J. sold $1,129,637 worth of ResMed Common Stock (4,991 units at $226.33) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form DEFA14A filed by ResMed Inc.
- SEC Form DEF 14A filed by ResMed Inc.